A retrospective observational study seeks to determine absolute risk of death due to CVD, cancer, and other causes in patients who experienced a severe hypoglycemic event.
Read More »Managing Editor, Diabetes in Control
The Role of Dapagliflozin in Patients with Type 2 Diabetes and Atrial Fibrillation
A post hoc analysis of the DECLARE-TIMI 58 trial may provide a new compelling indication for dapagliflozin.
Read More »Glycemic Benefit of Weekly GLP-1 Agonist: Albiglutide
Simple add-on therapy can reduce insulin use for patients with type 2 diabetes.
Read More »Major Reduction in Risk of Heart Attacks in Patients with Diabetes
Initiating the right medications upon diabetes diagnosis can help mitigate heart attack risk.
Read More »How Patients with T2DM Can Safely Consume Food with High Glycemic Index
A new study shows that a potato-based diet does not disturb blood sugar control in patients with type 2 diabetes mellitus (T2DM).
Read More »Gestational Diabetes and Related Outcomes in Singleton and Twin Pregnancies
Does gestational diabetes pose the same risks in twin pregnancies?
Read More »The Impact of Intensity Variation in Physical Activity on Mortality Rates
Does a higher percentage of vigorous physical activity as part of total exercise time confer additional benefits?
Read More »DNA Does Not Forget
Because of metabolic memory, complications of poor glucose control may not be reversed and will continue to progress even after glucose levels are normalized.
Read More »Risk of Anemia with Metformin Use in Patients with Type 2 Diabetes
Metformin use can reduce protein hemoglobin levels that carry oxygen in the blood.
Read More »Long-Acting GLP-1 Receptor Agonists vs. Short-Acting
Which GLP-1 is the most effective in getting patients to their goal?
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.